Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer.

Kwast AB, Liu L, Roukema JA, Voogd AC, Jobsen JJ, Coebergh JW, Soerjomataram I, Siesling S.

Br J Cancer. 2012 Jul 24;107(3):549-55. doi: 10.1038/bjc.2012.270. Epub 2012 Jun 19.

2.

Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.

Schaapveld M, Visser O, Louwman MJ, de Vries EG, Willemse PH, Otter R, van der Graaf WT, Coebergh JW, van Leeuwen FE.

J Clin Oncol. 2008 Mar 10;26(8):1239-46. doi: 10.1200/JCO.2007.11.9081.

3.

Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.

Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.

J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. doi: 10.1093/jnci/djn394. Epub 2008 Dec 9.

4.

Increased risk of second cancers following breast cancer: role of the initial treatment.

Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Lê MG.

Breast Cancer Res Treat. 2000 Jun;61(3):183-95.

PMID:
10965995
5.

Second primary breast cancer occurrence according to hormone receptor status.

Kurian AW, McClure LA, John EM, Horn-Ross PL, Ford JM, Clarke CA.

J Natl Cancer Inst. 2009 Aug 5;101(15):1058-65. doi: 10.1093/jnci/djp181. Epub 2009 Jul 9.

6.

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.

Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, Otter R, Coebergh JW, van Leeuwen FE.

Breast Cancer Res Treat. 2008 Jul;110(1):189-97. Epub 2007 Aug 9.

7.

The genetic epidemiology of second primary breast cancer.

Bernstein JL, Thompson WD, Risch N, Holford TR.

Am J Epidemiol. 1992 Oct 15;136(8):937-48.

PMID:
1456270
8.

Breast cancer risk factors and second primary malignancies among women with breast cancer.

Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM.

Breast Cancer Res Treat. 2007 Oct;105(2):195-207. Epub 2006 Dec 21.

PMID:
17186360
9.

Genetic implications of bilateral breast cancer: a population based cohort study.

Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P.

Lancet Oncol. 2005 Jun;6(6):377-82.

PMID:
15925815
10.

Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.

Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):679-90.

PMID:
11597809
11.

Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.

Werner-Wasik M, Schmid CH, Bornstein LE, Madoc-Jones H.

Cancer. 1995 May 1;75(9):2281-5.

13.

Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).

Molina-Montes E, Pollán M, Payer T, Molina E, Dávila-Arias C, Sánchez MJ.

Gynecol Oncol. 2013 Aug;130(2):340-5. doi: 10.1016/j.ygyno.2013.04.057. Epub 2013 May 4.

PMID:
23648471
14.

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MH, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2009 Sep 10;27(26):4239-46. doi: 10.1200/JCO.2008.19.9174. Epub 2009 Aug 10.

15.

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R.

J Clin Oncol. 1994 Feb;12(2):312-25.

PMID:
8113838
16.

Tamoxifen and risk of large bowel cancer in women with breast cancer.

Newcomb PA, Solomon C, White E.

Breast Cancer Res Treat. 1999 Feb;53(3):271-7.

PMID:
10369073
17.

Increased risk of second malignancies after in situ breast carcinoma in a population-based registry.

Soerjomataram I, Louwman WJ, van der Sangen MJ, Roumen RM, Coebergh JW.

Br J Cancer. 2006 Aug 7;95(3):393-7. Epub 2006 Jun 27.

18.

Second primary cancers in breast cancer patients in Slovenia.

Volk N, Pompe-Kirn V.

Cancer Causes Control. 1997 Sep;8(5):764-70.

PMID:
9328199
19.

Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.

Matsuyama Y, Tominaga T, Nomura Y, Koyama H, Kimura M, Sano M, Miura S, Takashima S, Mitsuyama S, Ueo H, Ohashi Y.

Ann Oncol. 2000 Dec;11(12):1537-43.

20.

Risk factors for contralateral breast cancer in Chennai (Madras), India.

Gajalakshmi CK, Shanta V, Hakama M.

Int J Epidemiol. 1998 Oct;27(5):743-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk